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1. Introduction 
Although primary hyperparathyroidism (pHPT) remains a relatively uncommon endocrine 
disease in Asian countries with an incidence ranging from 17 to 33 / 100,000 cases per year, 
it has been increasing over the last decade. (Bilezikian et al. 2000; Lo et al. 2004; Chen et al., 
2010) In contrast, in the Western world, pHPT is a relatively more common disease with an 
estimated incidence of 42 to 190/100,000 cases per year. Surgical treatment or 
parathyroidectomy remains the only curative therapy for patients with pHPT. The goal of 
surgery is to normalize postoperative calcium levels by excising all hyperfunctioning 
parathyroid tissue. Traditionally, this has been achieved by way of bilateral neck 
exploration (BNE) which involves examination of all four parathyroid glands and excision 
of any enlarged glands. However, with improvement in preoperative localization 
techniques and the commercial availability of quick intraoperative parathyroid hormone 
assay (IOPTH), an increasing number of endocrine surgeons are now performing minimally 
invasive parathyroidectomy (MIP). In experienced hands, many studies have found that 
MIP is not only a less invasive procedure associated with shorter hospital stay and less pain 
but also can achieve similar long-term cure rate of up to 95-98% as BNE which many would 
still regard it as the gold standard procedure. With this in mind, the purpose of this review 
is to look at the current views, issues and controversies associated with the use of 
preoperative localization studies, IOPTH and various surgical techniques of MIP by a 
comprehensive MEDLINE search using several specific keywords. These keywords include 
“minimally invasive parathyroidectomy”, “focused parathyroidectomy”, “intraoperative 
parathyroid hormone” and “parathyroid adenoma”. Since the success of MIP depends 
partly on the accuracy of preoperative localization studies and IOPTH, it is imperative to 
assess them in an evidence-based method. The review would look specifically on the use of 
99mTc Sestamibi (MIBI) and high-resolution ultrasound (USG) as both modalities are the 
most commonly employed and accurate imaging before MIP. The review would also look at 
the issues when there are concordant and discordant results between the MIBI and USG as 
well as examine the role of surgeon-performed USG (SPUS) in pHPT. Regarding the IOPTH, 
it remains controversial whether it should be routinely used in all cases of pHPT as some 
still question the cost-benefit and the “added value” of this particular operative adjunct. 
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Furthermore, there are still many unresolved issues regarding the most appropriate choice 
for IOPTH measurements and what criteria for defining biochemical cure. However, it is 
certain that the recent findings in IOPTH dynamics during MIP have helped us in better 
understanding of the disease itself. The previous concept of histology and gland size has 
now been challenged and is gradually being replaced by the concept of biochemical cure 
based on changes in IOPTH dynamics. Last and not the least, the review will look at various 
MIP techniques and evaluate which is most commonly used and performed and the reasons 
behind this. 
2. Surgical indications and guidelines 
The famous mneumonic "stones, bones, abdominal groans and psychiatric moans" 
concludes the symptoms of hyperparathyroidism or more specifically hypercalcemia. All 
patients suffering from the classical symptoms and signs of pHPT should undergo surgical 
treatment, as it is the only way for cure. On the other hand, the National Institute of Health 
(NIH) guidelines, as concluded at the third Workshop on the Management of asymptomatic 
pHPT, had a clear direction for the asymptomatic group of patients to choose between 
surgery and consideration of medical monitoring.  In treating the asymptomatic patients, we 
are aiming at reversing the decreased bone density, reducing the risk of fractures, reducing 
frequency of kidney stones and improving the neuro-cognitive elements. The consensus also 
stressed on the identification of Vitamin D deficiency, as it often complicates the diagnosis 
of pHPT. Therefore the optimal reference range of PTH assay should be based on adequate 
Vitamin D repletion, as physiologically, PTH and Vitamin D are closely inter-related. 
2.1 Surgical indications for “asymptomatic” patients  
According to the NIH guidelines, “asymptomatic” patients with the following features 
should undergo surgery: 
1. Hypercalcemia with serum calcium >1mg/dl above the upper limits of normal;  
2. Peri or post menopausal women, and men age >50 with a bone density T-score of -2.5 or 
less at the lumbar spine, femoral neck, total hip or 33% radius; Premenopausal women 
and in men younger age <50 with the bone density Z-score of -2.5 or less; Any patient 
with the presence of a fragility fracture. 
3. Age less than 50 
Table 1 summarized the changes in surgery criteria in the last decade. In the 2008 consensus, 
hypercalciuria was taken out from the guidelines because it is not a specific risk factor for 
kidney stones in primary hyperparathyroidism. However, it remains an important part of the 
initial workup to rule out familial hypocalciuric hypercalcemia. There were also questions over 
the accuracy of glomerular filtration rate (GFR) estimation by creatinine clearance and whether 
a numeral cut-point was better than an age invariant standard. The new consensus was made, 
based on the fact that a GFR of less than 60ml/min represented renal insufficiency to the 
extent that would cause parathyroid hormone elevation. The criteria “fracture fragility” was 
added to the newest guidelines because apart from bone mineral density, primary 
hyperparathyroidism would also affect the bone size and structure which in turn influence the 
fracture proclivity. Patients with age less than 50 were included as part of the targeted group 
as these patients would have greater risk of complications over time. 
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Measurement 1990 2002 2008 
Serum calcium 
(>upper limit of normal) 
1-1.6 mg/dl 1.0 mg/dl 1.0 mg/dl 
24 hour urine for calcium >400mg/d >400mg/d Not indicated 
Creatinine clearance 
(Calculated) 
Reduced by 30% Reduced by 30% 
Reduced to 
<60ml/min 
Bone Mineral Density 
Z-score <-2.0 in 
forearm 
T-score <-2.5 at any 
site 
T-score <-2.5 at any 
site and/or previous 
fracture fragility 
Age (yr) <50 <50 <50 
Table 1. Comparison of new and old guidelines for parathyroid surgery in asymptomatic 
primary hyperparathyroidism 
However, guidelines for normocalcaemic hyperparathyroidism were yet to be established 
with more evidence coming up. Parathyroid surgery should be performed only by highly 
experienced surgeon, or otherwise failure and complication will be unacceptably high and 
not cost effective. (Bilezikian et al., 2009) 
2.2 Are patients with pHPT truly asymptomatic? 
There is increasing evidence that patients with pHPT are not truly asymptomatic and if this 
proves to be true than all patients with pHPT would theoretically benefit from surgery. As a 
surgeon, it is not uncommon to see that patients with mild evidence of depression and 
anxiety at preoperative visits often improve after a successful parathyroidectomy. One of 
the explanations for this is that it is believed that there is a strong link between serum 
calcium levels and cognitive function. (Roman et al., 2011) In a general population cohort 
study of more than 4000 individuals, Schram et al. found that high serum calcium levels 
were associated with faster decline in cognitive function, especially for people older than 75 
years. This finding persisted even if people with abnormally high serum calcium levels were 
excluded.(Schram et al, 2007) Weber et al. evaluated 66 patients who underwent 
parathyroidectomy for pHPT pre-and postoperatively with 2 validated psychometric 
instruments and a health-related quality of life health survey (SF-12). They found that 
patients had significantly more depression and anxiety preoperatively than at 1 year 
postoperatively, whereas their physical functioning did not change. In this study, 
preoperative neuropsychological symptoms were related to the serum calcium 
levels.(Weber et al, 2007) Roman et al. studied 55 patients undergoing either 
parathyroidectomy for pHPT or thyroid resection for benign thyroid disease as controls and 
compared their neurocognitive test scores and psychological symptoms before and after 
surgery. They found that patients with pHPT reported more symptoms of depression and 
showed greater delays in spatial learning preoperatively than patients with thyroidectomy, 
but they improved significantly 1 month after surgery at a level equivalent to the controls. 
Interestingly, patients with greater change in PTH levels were more likely to improve in 
their learning efficiency after parathyroidectomy. (Roman et al., 2005) The same group also 
recently assessed the timing and magnitude of psychological and neurocognitive changes 
before and after parathyroidectomy and found significant improvements in psychological 
and neurocognitive measures at all postoperative visits. The most pronounced 
improvements were noted in depressive and anxiety symptoms, and visuospatial and verbal 
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memory. Examination of change scores revealed that postoperative reduction in PTH was 
associated with a decrease in state anxiety, which was also associated with improvement in 
visuospatial working memory.(Roman et al., 2011) 
3. Preoperative parathyroid localization 
Accurate preoperative localization plays a pivotal role in the success of MIP. Numerous 
imaging techniques such as technetium Tc99m sestamibi imaging (MIBI), high-resolution 
ultrasound (USG), magnetic resonance imaging (MRI), and computed tomography (CT) 
have been used to guide the surgeon and to assist with the preoperative planning. Among 
these imaging studies, MIBI and / or USG have been the two most commonly used 
preoperative imaging modalities because they are both readily available and relatively 
inexpensive. MRI and CT have also been advocated as second-line localization modalities as 
they do not appear to have better accuracy than MIBI or USG but they can localize inferiorly 
located or deeply seated parathyroid glands (e.g. mediastinal adenoma). When comparing 
the accuracy in detecting abnormal parathyroid glands between MIBI and USG, some have 
found that MIBI is more accurate than USG while other studies have found the opposite or 
similar accuracies. (Cheung et al., 2011) In our experience, MIBI has a higher overall 
sensitivity, accuracy and positive predicted value (PPV) in detecting abnormal parathyroid 
glands than USG (85%, 97% vs 94% vs. 57% vs 89%, 56%, respectively). (Lo et al., 2007) In 
fact, at our institution, we would rely more on the findings of the MIBI than USG. However, 
since USG could provide additional localization information in approximately 10-15% of 
patients with negative or equivocal MIBI, we have not abandoned the use of USG as a 
preoperative localizing tool.(Lo et al., 2007) In our clinical practice, all biochemically-
confirmed pHPT patients would undergo MIBI and if the MIBI is negative or equivocal, an 
additional USG by our radiologists would be performed. However, we would still perform 
an intraoperative USG by ourselves just before the skin incision to guide the placement of 
the small skin incision.  Our experiences with MIBI and USG have been consistent with 
those of other institutions. Quiros et al. reported their experience on 71 patients with pHPT 
who underwent both preoperative MIBI-SPECT and USG and found that if the MIBI was 
either negative or “ambiguous”, preoperative USG could localize an additional 14% of 
enlarged parathyroid glands and so further facilitate MIP in these patients.(Quiros et al., 
2004) Similarly, Adler et al. recently evaluated the added benefit of USG to MIBI in pHPT 
and reported that USG led to additional localization information in 14% of patients, 
although this benefit was less in patients with a clearly positive 1-gland MIBI scan. (Adler et 
al, 2011) Apart from MIBI and USG, 4D-CT has been shown to be a promising adjunct to 
other imaging studies. 4D-CT could provide exquisitely detailed, multiplanar images that 
accentuate the differences in the perfusion characteristics of hyperfunctioning parathyroid 
glands (i.e. rapid uptake and washout), compared with normal parathyroid glands and 
other structures of the neck.(Starker et al., 2011) In contrast to other axial imaging studies 
such as CT or MRI, the 4D-CT images could provide both anatomical information (which is 
vital for the surgeon) and functional information based on changes in perfusion in a single 
study. Starker et al. compared 4D-CT with MIBI and USG for parathyroid localization and 
found that 4D-CT had improved sensitivity (85.7%) over MIBI (40.4%) and USG (48.0%) in 
parathyroid localization. (Starker et al., 2011) Similarly, Cheung et al. recently reported the 
results of a meta-analysis of preoperative localization techniques which included MIBI, USG 
and 4D-CT in patients with pHPT. They found a total of 43 studies which met their inclusion 
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criteria and of these, 19 studies were on USG, 9 studies on MIBI-SPECT and 4 studies on 4D-
CT studies. USG had pooled sensitivity and PPV of 76.1% and 93.2%, respectively whereas 
MIBI-SPECT had a pooled sensitivity and PPV of 78.9% and 90.7%, respectively. 4D-CT had 
the highest sensitivity and PPV of 89.4% and 93.5%, respectively. Therefore, the authors 
concluded that MIBI-SPECT and USG had similar localization ability but 4D-CT may have 
improved accuracy. (Cheung et al., 2011) 
3.1 Patients with negative preoperative localization studies 
Patients with negative imaging represent an important subset of patients with pHPT 
because of increased frequency of multiglandular disease (38% vs 15% in patients with 
positive localization study). (Chan, R. K. et al., 2008) Because of the higher incidence of 
multiglandular disease, surgery needs to be conducted with a level of suspicion that 
multiglandular disease exists to ensure that all diseased glands are resected during the 
operation. In our experience, those with scan-negative and USG-negative results had 
significantly smaller sized parathyroid adenomas even if they only suffered from single 
gland disease.(Lo et al., 2007). The incidence of both MIBI- and USG-negative patients 
ranged between 12 – 18%. (Lo et al., 2007) One study compared the parathyroid histology 
between those with negative MIBI and with positive MIBI.(Mihai et al., 2006) They found 
that those with negative MIBI had a higher incidence of chief cells than those with positive 
MIBI, who had a higher incidence of oxyphilic cells. (Mihai et al., 2006) 
4. Surgical management 
While surgical intervention remains the only curative therapy for patients with 
hyperparathyroidism, conventional BNE with resection of enlarged parathyroid gland was 
the gold standard for treatment of pHPT. With the emerging preoperative and 
intraoperative localization technique as discussed in previous sections, focused-approach or 
MIP is coming to the throne. 
4.1 Definition of cure 
The general accepted definition of cure in publication is to achieve normocalcemia for at 
least 6 months postoperatively. Operative failure or persistent disease is defined as presence 
of hypercalcemia within 6 months of parathyroidectomy. Recurrent disease can be defined 
as recurrence of hypercalcemia after 6 months postoperative. 
4.2 Surgical options 
4.2.1 Conventional BNE 
BNE is the traditional surgical approach for management of pHPT. In general it gives a 
successful rate of greater than 95% and with complication rate of less than 4%. It involved a 
classic transverse incision at skin crease of about 5cm. All 4 parathyroid glands were 
identified and examined. All the morphologically abnormal glands were removed. IOPTH 
can be used as an adjunct for confirmation of cure. In case the IOPTH was negative, extra 
dissection may be needed to identify ectopic glands. A delayed second stage operation with 
relocalization by imaging can be considered if ectopic glands could not be found 
intraoperatively. (Augustine et al., 2011) 
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4.2.2 MIP 
MIP has now become the standard approach for surgical management of pHPT. It is the 
approach of choice for patients diagnosed with pHPT caused by a solitary parathyroid 
adenoma, and it is fast becoming an alternative approach in parathyroid reoperations. It 
comes in various forms and under various names; these include total endoscopic approach, 
video-assisted approach, radio-guided approach and mini-incision approach. In principle, 
however, they are similar, as they involve surgical excision of one single abnormal 
parathyroid gland (ie, adenoma) without disturbing the other three parathyroid glands. 
Therefore, a better collective name for them should be the focused approach. 
Although the extracervical approaches have been described for both unilateral and BNE, 
they have not been adopted widely. (Ikeda et al. 2000; Lang 2010) Among the endocrine 
surgeons, the most popular approach remains the open mini-incision approach with no 
video assistance. The mini-incision approach in MIP is technically similar to the one in MIT. 
Essentially a 2 cm incision is made at the medial border of SCM. The site of incision is 
marked after performing a bedside USG in the operating theater. The incision site is placed 
close to the localized parathyroid adenoma such that minimal tissue dissection is required. 
Like the mini-incision approach in MIT, a subplatysmal space is developed, and the plane 
between SCM and strap is opened up. Once the common carotid artery is identified, it is 
important to dissect all the way down to the prevertebral fascia medial to the artery such 
that the thyroid lobe and parathyroid glands can be retracted medially. At this point, the 
parathyroid adenoma usually is identified and carefully excised in whole. 
MIP is an operation associated with low morbidity and high success rates (greater than 
95%), but the operating surgeon should be meticulous, familiar with the anatomy, and 
experienced. Unlike the traditional open method where all four parathyroid glands are 
identified, MIP requires accurate preoperative localization of the abnormal parathyroid 
gland before it can be attempted. This is because in MIP, the operating surgeon would not 
have the benefit of examining the other three parathyroid glands; therefore, there is a 
possibility of missing underlying multiglandular disease such as double adenomas or four-
gland hyperplasia. In the author’s center, over 70% of patients with newly diagnosed pHPT 
will be eligible for MIP because of a positive preoperative localization by MIBI or USG. (Lo 
et al. 2007) To further improve the surgical success of MIP and to minimize the possibility  
of persistent or recurrent HPT after MIP, some have advocated the routine use of various 
surgical adjuncts such as radioguided probes or a quick IOPTH at the time of operation,  
but to date, their routine use remains questionable because of the marginal benefit and the 
high cost-to-benefit ratio. Nevertheless, MIP with or without the use of adjuncts, when 
performed in experienced hands has an equivalent success rate of greater than 95%, as the 
conventional four-gland exploration, and has all the benefits one expects from minimally 
invasive surgery. 
Similar to other minimally invasive procedures, MIP, when compared to conventional 
BNE, has obvious advantages as it decreases surgical morbidity in terms of cosmesis, 
pain, risk of recurrent laryngeal nerve injury, postoperative hypocalcaemia, etc. It can also 
reduce the cost, as well as the operative time and hospital stay. It is, in fact, currently an 
ambulatory surgery in many centres. Base on the fact that majority ~90% of patients with 
pHPT are having single hyperfunctioning adenoma, preoperative localization imaging 
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can often narrow down the pathology to the specific quadrant. A smaller, e.g. 2cm, 
incision is made over the suspected location of the adenoma. The authors adopted the 
lateral approach with dissection through the plane between the sternocleidomastoid 
muscle and the strap muscles. Dissection continued medial to the carotid artery to 
identify the prelocalised enlarged adenoma behind the thyroid gland. IOPTH can give 
extra confidence to the surgeon and to confirm cure of the disease. As we shall see later, 
there are increasing evidence that perhaps IOPTH may not be necessary, base on the fact 
that there is a high specificity of preoperative localization technique, especially in 
concordant MIBI and SUS. Udelsman et al. published data demonstrating the superior 
cure rate of MIP of 99.4% as compared to standard BNE of 97.1%.(Udelsman et al 2011). 
Suliburk et al also published the successful rate of MIP was as high as 98% even without 
IOPTH , depending on case selection.[6] The article also suggested that occult double 
adenoma was the major reason for failure. Among the 70% of the patients with double 
adenoma, the IOPTH has actually dropped by more than 50% after the first adenoma was 
removed. It is suggestive that the second adenoma remained dormant, or its function is 
suppressed until after the first adenoma is excised. Repeated MIBI scan after first 
operation can usually localize the second adenoma. On the other hand, in cases with 
hyperplasia or multiglandular disease (false positive MIBI), IOPTH may be useful. 
(Suliburk et al., 2011) [table 1] showed the published article on the outcome of MIP 
(Starker et al., 2011). 
4.2.3 Endoscopic/video-assisted parathyroidectomy 
Similar to MIP, endoscopic or video-assisted parathyroidectomy required accurate 
preoperative localization. Endoscopic instruments often provide better visualization of 
anatomic structures because of better lighting and magnification. An extra advantage of 
endoscope is that it can also facilitate mediastinal exploration from a transcervical approach.  
5. IOPTH 
Despite the fact that IOPTH has been commercially available for over 20 years, the issue of 
whether to routinely use it in MIP still remains unresolved. The arguments against its use 
mainly relates to the extra cost of the assay, the extra time required for the result to come 
back (i.e. extra theatre time), the inability in detecting multiglandular disease on some 
occasions and the limited added value in some select cases.( Stalberg et al., 2006; Suliburk, J. 
W. et al., 2011) Some groups without using IOPTH achieved similar cure rate as those with 
IOPTH. (Cho et al., 2011; Suliburk et al., 2011) As a result, some groups have advocated the 
use of IOPTH more selectively or in some situations such as in cases of discordant or 
equivocal localization studies. Kebebew et al. formulated a scoring system for this and 
suggested that patients with a score of 3 or more do not require IOPTH whereas a score of 
less than 3 would benefit from IOPTH. (Kebebew et al., 2006) Although these arguments 
may be true, most surgeons including us still prefer using IOPTH routinely in MIP. Some 
would argue that it is the “feel-good” factor which is important when performing this sort 
of a limited, focused approach parathyroidectomy because the surgeon do not have the 
benefit of looking at the other parathyroid glands and furthermore, the surgeon would be 
able to tell the patients and their relatives confidently that the IOPTH did drop after excision 
of the parathyroid gland.  
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First Author, Journal, 
year 
Study design 
Patient 
No. 
Preoperative 
localization 
method 
Success rate 
Intraoperativ
e Adjuncts 
Criteria 
Untch et al; J Am Coll 
Surg; Apr 2011 
Retrospective, 
2001-2010 
516 MIBI +/- USG 99.00% IOPTH 
50% 
reduction + 
normal 
Suliburk et al; ANZ J 
Surg; Feb 2010 
Retrospective, 
1998-2008 
1020 MIBI + USG 97.80% No IOPTH n/a 
Hwang et al; Ann Surg; 
Jun 2010 
Prospective, 
2006-2009 
280 
MIBI-SPECT + 
USG 
97.90% 
IOPTH in 
USG 
+ve/MIBI -ve  
Miami 
criterion 
(50% 
reduction) 
Lew et al; Surgery; Dec 
2009 
Retrospective, 
1993-1998 
173 MIBI 98.00% 
IOPTH +/- 
BIJVS 
Miami 
criterion 
(50% 
reduction) 
Lew et al; Arch Surg; Jul 
2009 
Retrospective, 
1993-2009 
845 MIBI +/- USG 97.10% IOPTH 
Miami 
criterion 
(50% 
reduction) 
Gill et al; Otolaryngol 
Head Neck Surg; Feb 
2011 
Retrospective 
2005-2009 
83 MIBI 97.00% IOPTH 
Miami 
criterion 
(50% 
reduction) 
Udelsman et al; Ann 
Surg; Mar 2011 
Retrospective 
1998-2009 
1037 MIBI / USG 99.40% IOPTH 
Miami 
criterion 
(50% 
reduction) 
Quillo et al; Am Surg; 
Apr 2011 
Retrospective, 
1999-2007 
198 MIBI 
100%  
(MIBI neg 
excluded) 
Radioguided 
Norman 
20% rule 
Adil et al; Otolaryngol 
Head Neck Surg; Mar 
2009 
Retrospective, 
1997-2007 
368 MIBI 
100%  
(MIBI neg 
excluded) 
Radioguided 
Norman 
20% rule 
Fouquet et al; 
Langenbecks Arch Surg; 
Aug 2010 
Retrospective 
2001-2008 
387 MIBI + USG 98.00% 
Total 
endoscopic 
lateral 
parathyroidec
tomy, IOPTH 
Miami 
criterion 
(50% 
reduction) 
Politz et al; Endocr 
Pract; Nov 2006 
Retrospective, 
2001-2004 
118 MIBI 
98%  
(MIBI neg 
excluded) 
Radioguided n/a 
Pang et al; Br J Surg; 
Mar 2007  
Retrospective, 
2000-2005 
500 MIBI +/- USG 97.40% No IOPTH n/a 
Mihai et al; Br J Surg; 
Jan 2007 
Retrospective, 
2001-2006 
298 
(150 
MIP, 
148 
BNE) 
MIBI + USG 97.30% No IOPTH n/a 
 Cohen et al; Surgery; 
Oct 2005 
Retrospective 
1999-2004 
139 
MIBI-SPECT 
+/- USG 
98.60% IOPTH 
Miami 
criterion 
(50% 
reduction) 
 
Table 2. Summary of recent studies on MIP, respective preoperative localization and 
intraoperative adjunts. 
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Nevertheless, the basis for using IOPTH in MIP is that after the removal of the 
hyperfunctioning or hypersecreting parathyroid adenoma or tissue, the serum PTH would 
drop and return to its normal range after a certain length of time provided that the 
remaining unexcised parathyroid glands are normal or not hyperfunctioning. Since the half-
life of PTH is only 2-3 minutes in the presence of normal renal function, the 
recommendation is that one would anticipate a 50% drop from the pre-excision IOPTH level 
in 10 minutes after excision of the abnormal parathyroid gland. The earliest method for 
monitoring IOPTH was described by Irvin et al. in 1991 and the recommendation for a 50% 
decline from preexcision IOPTH level was established in 1993. (Irvin et al., 1991, 1993)  
This is now known as the “Miami criterion”. In this criterion, a successful parathyroid 
operation is defined as a 50% or more decline from the highest preincision or preexcision 
IOPTH obtained 10 minutes after excision of the hyperfunctioning parathyroid gland. 
Therefore, as a surgeon who is using IOPTH, we have shifted the operation end-point  
from the conventional concept of “abnormal” parathyroid glands based on size and 
histology in the era of BNE exploration to the current concept of “hyperfunctioning” 
parathyroid glands with MIP and IOPTH monitoring. However, this shifting in concept still 
remains somewhat controversial. For example, we recently analyzed 161 consecutive 
patients who underwent parathyroidectomy (with the majority being MIP) for pHPT at our 
institution and found that approximately 40% of patients remained to have elevated PTH 
despite all had normocalcemia (i.e. eucalcemic PTH elevation) at 6-month and had > 50% 
decline in IOPTH at the time of operation.(Lang et al, 2011) This finding appeared to be 
consistent to other studies.(Oltmann et al., 2011)) Siperstein et al. showed that preoperative 
localizing studies and IOPTH failed to identify multiglandular disease in at least 16% of 
pHPT patients if routine BNE was employed in all patients.(Siperstein et al., 2008) This issue 
certainly raises concerns on whether by performing MIP and following the IOPTH criterion 
may lead to higher recurrences in the future. However, in many of the large (>1000  
cases) series of image-guided MIP with IOPTH, it is reassuring to find that the long-term 
cure rate does not appear to be inferior to conventional BNE.(Udelsman et al 2011; Suliburk, 
J. W. et al, 2011) 
The other issue relates to which is the best criterion for IOPTH in terms of highest 
sensitivity, and accuracy. There have been several studies comparing strategies for IOPTH 
testing. (Chiu et al., 2006; Carneiro et al., 2003; Barczynski et al., 2009) Barczynski et al. 
studied 260 patients with presumed solitary parathyroid adenomas based on concordant 
localization studies. The Miami criterion had the highest accuracy (97%) compared to the 
Halle (PTH level low normal at 15 minutes), Rome (>50% decline to normal at 20 minutes 
and / or < 7.5ng/L lower than the 10-minute value), and Vienna (≥50% decline at 10-
minutes) criteria. However, in this series, only 3.5% of patients had multiglandular disease 
and that is comparably low when it is believed that in the era of MIP, the incidence of 
multiglandular disease would be in the region of 10%. Since multiglandular disease remains 
one of the biggest downfalls or weaknesses of IOPTH, some groups have advocated to use a 
more stringent criterion. The Mayo clinic recently reported their experience of 1882 patients. 
In their series, the incidence of multiglandular disease was 22.0% and they defined a 
successful exploration as 1 50% or more decline in IOPTH level from baseline and a normal 
or near-normal IOPTH level at 10 minutes postexcision. They compared this criterion (or the 
Mayo criterion) with the Miami criterion and found that the Miami criterion would have 
missed 22.4% of patients with multiglandular disease. They concluded that relying on a 50% 
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decrease alone potentially increases the rate of operative failure in patients with 
multiglandular disease.(Richards et al., 2011) Therefore, it would appear that which is the 
best IOPTH criterion or strategy depends on the incidence of multiglandular disease at your 
own institution. In our experience, we believe the Miami criterion is the most convenient 
crierion, given the fact that we encounter very few multiglandular disease in our 
locality.(Lang et al, 2010, 2011) 
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